Clinical trial
Autologous Bone Marrow Mononuclear Cell Therapy in Cerebral Palsy
NCT02241395 is registered in ClinicalTrials.gov with Neurogen Brain and Spine Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Bone Marrow Mononuclear Cell Therapy in Cerebral Palsy
- Lead sponsor
- Neurogen Brain and Spine Institute
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- August 31, 2013
- Completion date
- December 31, 2018
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.